Home
PSNL
PSNL News

Latest Personalis Inc. (PSNL) News on February 22, 2025

Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

2 days ago

Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

Business Wire

4 days ago

Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

Business Wire

9 days ago

Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results

Business Wire

25 days ago

Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Personalis (PSNL) Upgraded to Buy: Here's Why

Zacks

a month ago

Personalis (PSNL) Upgraded to Buy: Here's Why

Researchers find ctDNA test predicts lung cancer outcomes in study

Medical Device Network

a month ago

Researchers find ctDNA test predicts lung cancer outcomes in study

MT Newswires

a month ago

Personalis Says Study Shows NeXT Personal Test's 'High Sensitivity' for Lung Cancer Detection

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer

Business Wire

a month ago

New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer

MT Newswires

a month ago

Personalis Reports Lower Preliminary Revenue for Q4

Business Wire

a month ago

Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue

The 16% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 159%

Simply Wall St.

2 months ago

The 16% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 159%

Personalis price target raised to $8 from $7 at BTIG

TipRanks

2 months ago

Personalis price target raised to $8 from $7 at BTIG

MT Newswires

2 months ago

Personalis Rallies Following $50 Million Investment from Merck, Extended Agreement With Moderna

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Business Wire

2 months ago

Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna

Tempus AI, Inc (TEM) Expands Partnership with Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma

Insider Monkey

2 months ago

Tempus AI, Inc (TEM) Expands Partnership with Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma

MT Newswires

2 months ago

Personalis, Tempus AI Expand Collaboration to Biopharma Industry

Personalis and Tempus Expand Collaboration to Biopharma

Business Wire

2 months ago

Personalis and Tempus Expand Collaboration to Biopharma

Personalis to Participate at Upcoming Investor Conferences

Business Wire

3 months ago

Personalis to Participate at Upcoming Investor Conferences

Here's Why We're Not Too Worried About Personalis' (NASDAQ:PSNL) Cash Burn Situation

Simply Wall St.

3 months ago

Here's Why We're Not Too Worried About Personalis' (NASDAQ:PSNL) Cash Burn Situation

Personalis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

3 months ago

Personalis Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Personalis Inc (PSNL) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid Strategic ...

GuruFocus.com

3 months ago

Personalis Inc (PSNL) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid Strategic ...

Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates

Zacks

4 months ago

Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates

Associated Press Finance

4 months ago

Personalis: Q3 Earnings Snapshot

Business Wire

4 months ago

Personalis Reports Third Quarter 2024 Financial Results

Business Wire

4 months ago

Personalis to Present at the Stifel 2024 Healthcare Conference

Personalis Inc (PSNL) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

4 months ago

Personalis Inc (PSNL) Q3 2024 Earnings Report Preview: What To Expect

Personalis to Announce Third Quarter 2024 Financial Results

Business Wire

4 months ago

Personalis to Announce Third Quarter 2024 Financial Results

MT Newswires

5 months ago

Personalis Awarded New Task Order Under US Department of Veterans Affairs Contract

Personalis, Inc. (NASDAQ:PSNL) has caught the attention of institutional investors who hold a sizeable 38% stake

Simply Wall St.

5 months ago

Personalis, Inc. (NASDAQ:PSNL) has caught the attention of institutional investors who hold a sizeable 38% stake

ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test

Business Wire

5 months ago

ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test

Business Wire

6 months ago

Personalis to Participate at Upcoming Investor Conferences

Why Tempus AI Stock Skyrocketed Nearly 22% Today

Motley Fool

6 months ago

Why Tempus AI Stock Skyrocketed Nearly 22% Today

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MT Newswires

6 months ago

BTIG Raises Personalis' Price Target to $7 From $5.50, Buy Rating Maintained

MT Newswires

6 months ago

Personalis, Tempus Rally Friday on Expanded Collaboration Pact

Personalis and Tempus Announce Expanded Collaboration

Business Wire

6 months ago

Personalis and Tempus Announce Expanded Collaboration

Personalis, Inc. (PSNL) Hit a 52 Week High, Can the Run Continue?

Zacks

6 months ago

Personalis, Inc. (PSNL) Hit a 52 Week High, Can the Run Continue?

Personalis Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Personalis Second Quarter 2024 Earnings: Beats Expectations

MT Newswires

6 months ago

Needham Adjusts Personalis' PT to $5.50 From $3.50, Keeps Buy Rating

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Zacks

6 months ago

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Associated Press Finance

6 months ago

Personalis: Q2 Earnings Snapshot

Business Wire

6 months ago

Personalis Reports Second Quarter 2024 Financial Results

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

GlobeNewswire

7 months ago

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

Business Wire

7 months ago

Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Business Wire

7 months ago

Personalis to Announce Second Quarter 2024 Financial Results

Even after rising 48% this past week, Personalis (NASDAQ:PSNL) shareholders are still down 89% over the past three years

Simply Wall St.

7 months ago

Even after rising 48% this past week, Personalis (NASDAQ:PSNL) shareholders are still down 89% over the past three years

Myriad Genetics (MYGN) Expands in MRD Testing With New Collab

Zacks

7 months ago

Myriad Genetics (MYGN) Expands in MRD Testing With New Collab

MT Newswires

7 months ago

Myriad Genetics, Personalis to Cross-License IP on Minimal Residual Disease Tests

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

GlobeNewswire

7 months ago

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

Business Wire

8 months ago

Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference

Business Wire

8 months ago

Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call

ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring

Business Wire

9 months ago

ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring

Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus

Business Wire

9 months ago

Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus

Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024

Business Wire

9 months ago

Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

9 months ago

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript

Is Personalis (NASDAQ:PSNL) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

9 months ago

Is Personalis (NASDAQ:PSNL) In A Good Position To Deliver On Growth Plans?

Personalis First Quarter 2024 Earnings: US$0.26 loss per share (vs US$0.61 loss in 1Q 2023)

Simply Wall St.

9 months ago

Personalis First Quarter 2024 Earnings: US$0.26 loss per share (vs US$0.61 loss in 1Q 2023)

Thomson Reuters StreetEvents

9 months ago

Q1 2024 Personalis Inc Earnings Call

GuruFocus.com

9 months ago

Personalis Inc (PSNL) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Revenue ...

Associated Press Finance

9 months ago

Personalis: Q1 Earnings Snapshot

Business Wire

9 months ago

Personalis Reports First Quarter 2024 Financial Results

Personalis to Announce First Quarter 2024 Financial Results

Business Wire

10 months ago

Personalis to Announce First Quarter 2024 Financial Results

Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

a year ago

Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Business Wire

a year ago

Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring

Business Wire

a year ago

Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Personalis, Inc. (NASDAQ:PSNL) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Personalis, Inc. (NASDAQ:PSNL) Q4 2023 Earnings Call Transcript

Associated Press Finance

a year ago

Personalis: Q4 Earnings Snapshot

Personalis Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

a year ago

Personalis Reports Fourth Quarter and Full Year 2023 Financial Results

Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results

Business Wire

a year ago

Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results

PodcastOne (Nasdaq: PODC) to Announce Third Quarter Fiscal 2024 Financial Results and Host Investor Webcast on February 8, 2024

GlobeNewswire

a year ago

PodcastOne (Nasdaq: PODC) to Announce Third Quarter Fiscal 2024 Financial Results and Host Investor Webcast on February 8, 2024

Business Wire

a year ago

Personalis to Participate at Upcoming Investor Conferences

Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology

Business Wire

a year ago

Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks

StockStory

a year ago

Q3 Rundown: Best Buy Co (NYSE:BBY) Vs Other Specialty Retail Stocks

L.B. Foster Company to Nominate Alexander B. Jones from 22NW, LP to Stand for Election to the L.B. Foster Board of Directors at 2024 Annual Meeting of Shareholders

GlobeNewswire

a year ago

L.B. Foster Company to Nominate Alexander B. Jones from 22NW, LP to Stand for Election to the L.B. Foster Board of Directors at 2024 Annual Meeting of Shareholders

Associated Press Finance

a year ago

Five Point: Q4 Earnings Snapshot

Five Point Holdings, LLC Reports Fourth Quarter and Year-End 2023 Results

Business Wire

a year ago

Five Point Holdings, LLC Reports Fourth Quarter and Year-End 2023 Results

With 35% stake, Pegasus Digital Mobility Acquisition Corp. (NYSE:PGSS) seems to have captured institutional investors' interest

Simply Wall St.

a year ago

With 35% stake, Pegasus Digital Mobility Acquisition Corp. (NYSE:PGSS) seems to have captured institutional investors' interest

Sify reports Consolidated Financial Results for Q3 FY 2023-24

GlobeNewswire

a year ago

Sify reports Consolidated Financial Results for Q3 FY 2023-24

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Reuters

a year ago

Emergent extends shelf life of opioid overdose reversal drug Narcan

OVBC ANNOUNCES CASH DIVIDEND

PR Newswire

a year ago

OVBC ANNOUNCES CASH DIVIDEND

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

Business Wire

a year ago

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine

Zacks

a year ago

Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine

5 Small-Cap Stocks to Play the January Effect

Zacks

a year ago

5 Small-Cap Stocks to Play the January Effect

Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance

Business Wire

a year ago

Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance

Franklin Covey (FC) Q1 Earnings and Revenues Top Estimates

Zacks

a year ago

Franklin Covey (FC) Q1 Earnings and Revenues Top Estimates

Retail investors account for 42% of CNFinance Holdings Limited's (NYSE:CNF) ownership, while institutions account for 29%

Simply Wall St.

a year ago

Retail investors account for 42% of CNFinance Holdings Limited's (NYSE:CNF) ownership, while institutions account for 29%

ESSA Bancorp Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

a year ago

ESSA Bancorp Full Year 2023 Earnings: Beats Expectations

Even With A 37% Surge, Cautious Investors Are Not Rewarding Personalis, Inc.'s (NASDAQ:PSNL) Performance Completely

Simply Wall St.

a year ago

Even With A 37% Surge, Cautious Investors Are Not Rewarding Personalis, Inc.'s (NASDAQ:PSNL) Performance Completely

Sandy Spring Bancorp (SASR) Stock Jumps 9.3%: Will It Continue to Soar?

Zacks

a year ago

Sandy Spring Bancorp (SASR) Stock Jumps 9.3%: Will It Continue to Soar?

Loop Industries Announces Its Loop(TM) Branded PET Resin Is Compliant for Pharmaceutical Industry Packaging Applications

ACCESSWIRE

a year ago

Loop Industries Announces Its Loop(TM) Branded PET Resin Is Compliant for Pharmaceutical Industry Packaging Applications

3 Vulnerable Retail Stocks That Won’t Survive the Holidays

InvestorPlace

a year ago

3 Vulnerable Retail Stocks That Won’t Survive the Holidays

3 Niche Tech Stocks With Untapped Potential

InvestorPlace

a year ago

3 Niche Tech Stocks With Untapped Potential

Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)

GuruFocus.com

a year ago

Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)

Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives

Business Wire

a year ago

Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives

Levicept Appoints Eliot Forster as CEO

GlobeNewswire

a year ago

Levicept Appoints Eliot Forster as CEO

Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing

Business Wire

a year ago

Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing

Share on Social Networks: